# Validation of a Composite Medical Device Using a Blood Biomarker-based Algorithm and MDQ for the Diagnosis of Bipolar Disorder

> **NCT07031817** · NA · RECRUITING · sponsor: **University Hospital, Montpellier** · enrollment: 623 (estimated)

## Conditions studied

- Bipolar Disorder (BD)
- Major Depressive Episode (MDE)
- Primary Care
- Major Depression

## Interventions

- **DIAGNOSTIC_TEST:** Venous blood sample for measuring blood biomarkers related to bipolar disorder
- **OTHER:** Standardized psychiatric assessment tools

## Key facts

- **NCT ID:** NCT07031817
- **Lead sponsor:** University Hospital, Montpellier
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-09-30
- **Primary completion:** 2027-10-01
- **Final completion:** 2028-07-01
- **Target enrollment:** 623 (ESTIMATED)
- **Last updated:** 2025-10-07

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07031817

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07031817, "Validation of a Composite Medical Device Using a Blood Biomarker-based Algorithm and MDQ for the Diagnosis of Bipolar Disorder". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT07031817. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*